Tenax Therapeutics, Inc.
Nasdaq TENX · Chapel Hill, NC
Works in Cardiovascular · Neurology · Respiratory
Tenax Therapeutics, Inc. is a clinical trial sponsor based in Chapel Hill, NC, listed as Nasdaq TENX. It has 3 active clinical trials with 1,570 planned participants, in Cardiovascular, Neurology and Respiratory. Since 2021 it has completed 2 trials and stopped 1 early.
Trial track record · since 2021
Financials · Nasdaq TENX
Fundraising
Pipeline · 3 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about Tenax Therapeutics, Inc
Tenax Therapeutics, Inc is lead sponsor of 3 active clinical trials on ClinicalTrials.gov, with 1,570 planned participants, in Cardiovascular, Neurology, Respiratory. Since 2021 it has completed 2 trials and stopped 1 early.
Tenax Therapeutics, Inc is based in Chapel Hill, NC and is listed as Nasdaq TENX. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Tenax Therapeutics, Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-15.
Approve Suite is not affiliated with Tenax Therapeutics, Inc..
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.